Brief: Vesicor Therapeutics And Black Hawk Acquisition Corporation Enter Into A Business Combination Agreement
28/04/2025 22:52
April 28 (Reuters) - Black Hawk Acquisition Corp BKHA.O: VESICOR THERAPEUTICS, INC. AND BLACK HAWK ACQUISITION CORPORATION ENTER INTO A BUSINESS COMBINATION AGREEMENT TO CREATE A BIOTECHNOLOGY COMPANY ADVANCING P53-BASED CANCER THERAPEUTICS DELIVERED VIA MICROVESICLES BLACK HAWK ACQUISITION CORP - VESICOR VALUED AT PRE-MONEY EQUITY VALUE OF $70 MILLION Source text: ID:nGNX44wRYQ Further company coverage: BKHA.O (Reuters.Briefs@thomsonreuters.com)